New: NCI-funded clinical trial search
Mednet Logo

What do you consider a curative radiation dose for a sarcoma?

If a patient with a high grade sarcoma has gross residual/recurrent disease after resection and cannot undergo further surgery - would you boost this to a higher dose? 70Gy?
5 Answers
Mednet MemberInvited Expert
Surgical Oncology · Temple University
Answered on

This is a difficult predicament. We would certainly try to re-resect if at all possible; if not, a consideration could always be made for an amputation, but we try to avoid this if at all possible. Other options during the time of resection are consideration for brachytherapy. We would also discuss systemic therapy and clinical trials. There are some series on the use of regional therapy for extremity sarcomas with limb infusion for recurrent or unresectable sarcomas.

Related to your question, we would consider a radiation boost to the tumor; we usually try to consider a dose of 70Gy with at least 2Gy per fraction, or the BED equivalent.

Join for free or sign in to see the full answer

Mednet MemberInvited Expert
Radiation Oncology · University of Florida
Answered on

Unresectable means either extensive or terrible location. Subtotal resection won’t help and will likely contaminate adjacent tissues. Plus the tumor may be displacing OAR. So use as much dose as you can get away with, and reasonably minimize the risk of a disastrous complication. There will be no salvage, so failure to control the tumor will be as bad or worse than a complication. 70 Gy/35 fractions or more. Accelerate if possible. The dose will depend on adjacent OAR.

Join for free or sign in to see the full answer

Mednet MemberInvited Expert
Radiation Oncology · Allegheny Health Network, Pittsburgh
Answered on

With gross residual disease that is unresectable, the question is whether there is a curative dose per se. It's reasonable to consider 70 gy. While not in this clinical situation, there is some data on sbrt for oligometastatic sarcoma for gross disease.

Join for free or sign in to see the full answer

Mednet MemberInvited Expert
Radiation Oncology · AdventHealth
Answered on

Excellent question and I agree with all the above points. SBRT is an excellent choice for smaller lesions, <5 cm.

Targeting 70 Gy is reasonable with modern intensity modulated RT. There are some data to be aware of that can assist in formulating a strategy:

Join for free or sign in to see the full answer

Mednet MemberInvited Expert
Medical Oncology · University of Miami Sylvester Comprehensive Cancer Center
Answered on

Recurrence: I agree with the above. It’s challenging to speak with certainty without details. In general: in this situation we prefer not to radiate gross residual disease. We would likely use chemotherapy to cytoreduce, then reresect or radiate.

Gross residual disease: this situation is exceptionally rare at experienced sarcoma centers. Surgery is generally not performed if gross residual disease is expected (unless palliative).

Join for free or sign in to see the full answer